Who would be the first to get a COVID-19 vaccine?
Who would be the first to get a COVID-19 vaccine?
Probably people in the country where the first effective vaccine is developed.
RELATED: CoronavirusNOW.com, FOX launches national hub for COVID-19 news and updates
About a dozen different vaccines are in various stages of testing worldwide, including in Britain, China and the U.S. This week, Dr. Anthony Fauci, the top U.S. infectious disease expert, said he is cautiously optimistic there will be a COVID-19 vaccine by the end of the year or early 2021.
Several wealthy countries have already ordered millions of doses of those experimental vaccines.
![Health Professionals At Work During their Shift at the ICU of Mater Dei Hospital in Belo Horizonte Amidst the Coronavirus (COVID 19) Pandemic](https://images.foxtv.com/static.fox32chicago.com/www.fox32chicago.com/content/uploads/2020/06/932/524/GettyImages-1222128476.jpg?ve=1&tl=1)
A medical team employee prepares vaccine at the ICU of Mater Dei hospital amid the coronavirus (COVID-19) pandemic on June 23, 2020 in Belo Horizonte, Brazil. (Photo by Pedro Vilela/Getty Images)
Britain and the U.S., for example, have invested in a vaccine candidate being developed by Oxford University and produced by AstraZeneca. If it works, U.K. politicians have said Britons will be vaccinated with it. The U.S. expects to start stockpiling it this fall and also has invested in other vaccine candidates.
RELATED: New CDC model predicts up to 150,000 American COVID-19 deaths by mid-July
Groups including the vaccine alliance GAVI are also working to buy doses for poor countries and AstraZeneca has agreed to license its vaccine to India’s Serum Institute for the production of 1 billion doses. The World Health Organization is drafting guidelines for the ethical distribution of COVID-19 vaccines.
How vaccines are distributed within a country will vary. Last week, U.S. officials said they were developing a tiered system for that. The system would likely prioritize groups at greatest risk of severe complications from COVID-19 and key workers.
___